MOTS OTC
Motus GI Holdings, Inc.
1W: +0.0%
1M: +100.0%
3M: +100.0%
YTD: +100.0%
1Y: +1900.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±9950.3%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.00001-0.1
Volume250
Avg Volume1,907
Beta-5.94
Dividend—
Analyst Ratings
Company Info
CEOMark Pomeranz
Employees15
SectorHealthcare
IndustryMedical - Devices
IPO Date2018-02-14
Websitemotusgi.com
1301 East Broward Boulevard
Fort Lauderdale, FL 33301
US
Fort Lauderdale, FL 33301
US
954 541 8000
About Motus GI Holdings, Inc.
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Durbin Scott | A-Award | 23,205 | $0.62 | 2024-03-05 |
| Nelson Sonja | A-Award | 23,205 | $0.62 | 2024-03-05 |
| Pruden Gary J | A-Award | 23,205 | $0.62 | 2024-03-05 |
| Moran Timothy P. | A-Award | 23,205 | $0.62 | 2024-03-05 |
| Orchestra BioMed Hol | 0 | — | 2023-09-12 |